{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:12:18Z","timestamp":1762459938010,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"FWO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ijid.2021.02.068","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T13:01:01Z","timestamp":1613739661000},"page":"217-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The hepatitis C cascade of care in the Belgian HIV population: One step closer to elimination"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0887-4119","authenticated-orcid":false,"given":"Dana","family":"Busschots","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zg\u00fcr M.","family":"Koc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leen","family":"Heyens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Bielen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig","family":"Apers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Florence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Messiaen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristel","family":"Van Laethem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Van Wijngaerden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Nevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niel","family":"Hens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"Robaeys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ijid.2021.02.068_bib0005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2143\/ACB.3315","article-title":"Incidence of HCV and sexually transmitted diseases among HIV positive MSM in Antwerp, Belgium, 2001\u20132011","volume":"68","author":"Apers","year":"2013","journal-title":"Acta Clin Belg"},{"issue":"5","key":"10.1016\/j.ijid.2021.02.068_bib0010","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/QAI.0000000000000528","article-title":"Risk factors for HCV acquisition among HIV-positive MSM in Belgium","volume":"68","author":"Apers","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"year":"2015","series-title":"Recente informatie januari 2015: tapentadol, alemtuzumab, simeprevir en sofosbuvir, levothyroxine (L-thyroxine\u00ae)","author":"BCFI","key":"10.1016\/j.ijid.2021.02.068_bib0015"},{"issue":"2","key":"10.1016\/j.ijid.2021.02.068_bib0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4254\/wjh.v8.i2.92","article-title":"Chronic hepatitis C: this and the new era of treatment","volume":"8","author":"Bertino","year":"2016","journal-title":"World J Hepatol"},{"issue":"9","key":"10.1016\/j.ijid.2021.02.068_bib0025","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/cid\/cix1004","article-title":"High treatment uptake in HIV\/HCV-coinfected patients after unrestricted access to direct-acting antivirals in the Netherlands","volume":"66","author":"Boerekamps","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.068_bib0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12879-020-4898-y","article-title":"Eliminating viral hepatitis C in Belgium: the micro-elimination approach","volume":"20","author":"Busschots","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10.1016\/j.ijid.2021.02.068_bib0035","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1089\/aid.2011.0004","article-title":"A comparison of treatment eligibility for hepatitis C virus in HCV-monoinfected versus HCV\/HIV-coinfected persons in electronically retrieved cohort of HCV-infected veterans","volume":"27","author":"Butt","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"7","key":"10.1016\/j.ijid.2021.02.068_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102883","article-title":"The hepatitis C cascade of care among HIV infected patients: a call to address ongoing barriers to care","volume":"9","author":"Cachay","year":"2014","journal-title":"PLoS One"},{"year":"2020","series-title":"Compliant with ISO standards","author":"Castor EDC","key":"10.1016\/j.ijid.2021.02.068_bib0045"},{"year":"2007","series-title":"Guidelines for the clinical management and treatment of HIV infected adults in Europe","author":"EACS","key":"10.1016\/j.ijid.2021.02.068_bib0050"},{"year":"2018","series-title":"Quantifying fibrosis with FibroScan","author":"Echosens","key":"10.1016\/j.ijid.2021.02.068_bib0055"},{"issue":"5","key":"10.1016\/j.ijid.2021.02.068_bib0060","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/hep.27310","article-title":"Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada","volume":"60","author":"Jacka","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.068_bib0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12889-018-6347-z","article-title":"Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up","volume":"19","author":"Litzroth","year":"2019","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ijid.2021.02.068_bib0070","doi-asserted-by":"crossref","first-page":"e25062","DOI":"10.1002\/jia2.25062","article-title":"Is hepatitis C virus elimination possible among people living with HIV and what will it take to achieve it?","volume":"21 Suppl 2","author":"Martin","year":"2018","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"10.1016\/j.ijid.2021.02.068_bib0075","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.idc.2018.02.004","article-title":"Understanding and addressing HCV reinfection among men who have sex with men","volume":"32","author":"Martin","year":"2018","journal-title":"Infect Dis Clin North Am"},{"issue":"30","key":"10.1016\/j.ijid.2021.02.068_bib0080","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.30.1800614","article-title":"Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU\/EEA: a systematic review","volume":"24","author":"Mason","year":"2019","journal-title":"Euro Surveill"},{"issue":"6","key":"10.1016\/j.ijid.2021.02.068_bib0085","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/cid\/ciq200","article-title":"Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C","volume":"52","author":"Matthews","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"18","key":"10.1016\/j.ijid.2021.02.068_bib0090","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1097\/QAD.0b013e32801086da","article-title":"Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic","volume":"20","author":"Mehta","year":"2006","journal-title":"Aids"},{"issue":"4","key":"10.1016\/j.ijid.2021.02.068_bib0095","first-page":"479","article-title":"Hepatitis C virus (HCV) prevalence estimation in the adult general population in Belgium: a meta-analysis","volume":"82","author":"Muyldermans","year":"2019","journal-title":"Acta Gastroenterol Belg"},{"issue":"5","key":"10.1016\/j.ijid.2021.02.068_bib0100","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/apc.2014.0033","article-title":"Barriers to hepatitis C antiviral therapy in HIV\/HCV co-infected patients in the United States: a review","volume":"28","author":"Oramasionwu","year":"2014","journal-title":"AIDS Patient Care STDS"},{"issue":"10","key":"10.1016\/j.ijid.2021.02.068_bib0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185866","article-title":"Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users","volume":"12","author":"Paraschiv","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijid.2021.02.068_bib0110","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL recommendations on treatment of hepatitis C 2018","volume":"69","author":"Pawlotsky","year":"2018","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.ijid.2021.02.068_bib0115","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jinf.2015.07.006","article-title":"Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C","volume":"71","author":"Pineda","year":"2015","journal-title":"J Infect"},{"issue":"7","key":"10.1016\/j.ijid.2021.02.068_bib0120","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1473-3099(15)00485-5","article-title":"Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis","volume":"16","author":"Platt","year":"2016","journal-title":"Lancet Infect Dis"},{"year":"2018","series-title":"Antivirale geneesmiddelen tegen hepatitis C: vergoedingsvoorwaarden vanaf 1 januari 2017","author":"RIZIV","key":"10.1016\/j.ijid.2021.02.068_bib0125"},{"issue":"6","key":"10.1016\/j.ijid.2021.02.068_bib0130","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jhep.2016.07.042","article-title":"Global genotype distribution of hepatitis C viral infection among people who inject drugs","volume":"65","author":"Robaeys","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijid.2021.02.068_bib0135","doi-asserted-by":"crossref","first-page":"e25051","DOI":"10.1002\/jia2.25051","article-title":"Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era","volume":"21 Suppl 2","author":"Sacks-Davis","year":"2018","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"10.1016\/j.ijid.2021.02.068_bib0140","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/14787210.2018.1471355","article-title":"Eliminating HIV\/HCV co-infection in gay and bisexual men: is it achievable through scaling up treatment?","volume":"16","author":"Sacks-Davis","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"year":"2018","series-title":"Epidemiologie van AIDS en HIV-infectie in Belgi\u00eb","author":"Sasse","key":"10.1016\/j.ijid.2021.02.068_bib0145"},{"issue":"5","key":"10.1016\/j.ijid.2021.02.068_bib0150","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa040842","article-title":"Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients","volume":"351","author":"Torriani","year":"2004","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.ijid.2021.02.068_bib0155","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1097\/QAD.0000000000001592","article-title":"Limited overlap between phylogenetic HIV and hepatitis C virus clusters illustrates the dynamic sexual network structure of Dutch HIV-infected MSM","volume":"31","author":"Vanhommerig","year":"2017","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.ijid.2021.02.068_bib0160","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1478-3231.2010.02305.x","article-title":"Phylogenetic analysis of acute hepatitis C virus genotype 4 infections among human immunodeficiency virus-positive men who have sex with men in Germany","volume":"30","author":"Vogel","year":"2010","journal-title":"Liver Int"},{"year":"2016","series-title":"Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection","author":"WHO","key":"10.1016\/j.ijid.2021.02.068_bib0165"},{"year":"2017","series-title":"Global hepatitis report, 2017","author":"WHO","key":"10.1016\/j.ijid.2021.02.068_bib0170"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.068_bib0175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/hep.27366","article-title":"Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virus","volume":"61","author":"Yoshida","year":"2015","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.ijid.2021.02.068_bib0180","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/cid\/cix126","article-title":"Risk factors for hepatitis C Virus reinfection after sustained virologic response in patients coinfected with HIV","volume":"64","author":"Young","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2021.02.068_bib0185","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000437427","article-title":"Treatment of acute hepatitis C infection with pegylated interferon and ribavirin in patients coinfected with human immunodeficiency virus: a systematic review and meta-analysis","volume":"58","author":"Zhang","year":"2015","journal-title":"Intervirology"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221001545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221001545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:58:00Z","timestamp":1761119880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221001545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":37,"alternative-id":["S1201971221001545"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.02.068","relation":{},"ISSN":["1201-9712"],"issn-type":[{"type":"print","value":"1201-9712"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The hepatitis C cascade of care in the Belgian HIV population: One step closer to elimination","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.02.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}